180P FIRE-6: Longitudinal immune profiling identified disturbed NK cell functionality in RAS/BRAF wild-type metastatic colorectal cancer patients and during combined treatment with FOLFIRI, cetuximab followed by avelumab maintenance. - Schiele, P.; Kolling, S.; Stintzing, S.; Junkuhn, C.; Walter, A.; Rosnev, S.; von Einem, J.; Schöning, W.; Sauer, I.; Modest, D.P.; Heinrich, K.; Weiss, L.; et al. (Annals of Oncology, 2024)